1. Gastric Campylobacter-like organisms, gastritis, and peptic ulcer disease;Blazer, M.J.;Gastroenterology,1987
2. Campylobacter pylori degrades mucin and undermines gastric mucosal integrity;Slomiany, B.L.; Bilski, J.; Sarosiek, J.;BiochemBiophysRes Commun,1987
3. Effect of treatment on Campylobacter pylori in pectic disease: a randomised prospective trial;Humphreys, H.; Bourke, S.; Dooley, C.;Gut,1988
4. Gastric mucosal damage induced by local intra-arterial administration of paf in the rat;Esplugues, J.V.; Whittle, B.J.R.;BrJ Pharmacol,1988
5. Semi-synthese et structure proposee du facteur activant les plaquettes (PAF): Paf-acether un alkyl-ether analogue de la lysophosphatidylcholine;Benveniste, J.; Tence, M.; Varenne, P.; Boullet, C.; Polonsky, J.;CR Acad Sci Paris,1979